Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ROGERS CORPROG · Entity 4438 | Director | May 06, 2026 | May 08, 2026 |
| indie Semiconductor, Inc.INDI · Entity 2432 | Director | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ROGERS CORP
Report date May 06, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Capital (Common) StockSEC Table I · non-derivative | Direct | 13,487 |
Reported balance
After 2026-05-06 transaction · row 1
1 source rowRow 1 · 2026-05-06 · Grant · Acquired 1,427 · Balance 13,487 F1: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 6, 2026, award of deferred stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 6, 2026, award of deferred stock units.
indie Semiconductor, Inc.
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 227,572 |
Reported balance
After 2026-09-01 transaction · row 1
1 source rowRow 1 · 2026-09-01 · Exercise / conversion · Acquired 2,641 · Balance 227,572 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,641 |
Reported balance
After 2026-09-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-01 · Grant · Acquired 2,641 · Balance 2,641 F1: Each Restricted Stock Unit represents a contingent right to receive one share of Class A Common Stock. F2: Represents Restricted Stock Units that were fully vested as of the grant date. These Restricted Stock Units represent shares received in lieu of a quarterly cash retainer and chairperson fees, if any, as part of a voluntary independent director compensation program as approved by the Board of Directors in June 2023. The number of underlying shares is equal to the amount of the forgone quarterly cash retainer and chairperson fees, if any, divided by the closing trading price of INDI on the date of grant. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-09-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-01 · Exercise / conversion · Disposed 2,641 · Balance 0 F1: Each Restricted Stock Unit represents a contingent right to receive one share of Class A Common Stock. F2: Represents Restricted Stock Units that were fully vested as of the grant date. These Restricted Stock Units represent shares received in lieu of a quarterly cash retainer and chairperson fees, if any, as part of a voluntary independent director compensation program as approved by the Board of Directors in June 2023. The number of underlying shares is equal to the amount of the forgone quarterly cash retainer and chairperson fees, if any, divided by the closing trading price of INDI on the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit represents a contingent right to receive one share of Class A Common Stock.
F2: Represents Restricted Stock Units that were fully vested as of the grant date. These Restricted Stock Units represent shares received in lieu of a quarterly cash retainer and chairperson fees, if any, as part of a voluntary independent director compensation program as approved by the Board of Directors in June 2023. The number of underlying shares is equal to the amount of the forgone quarterly cash retainer and chairperson fees, if any, divided by the closing trading price of INDI on the date of grant.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Aptiv PLC
Report date February 17, 2017 · Filed February 22, 2017
Section 16 reporting ended · disclosed 2017-02-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 46,592 |
Ending reported balance
After 2017-02-17 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2017-02-17 · Other · Acquired 865 · Balance 47,651 F1: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrued when and as dividends were paid on the Issuer's ordinary shares and vested proportionately with the restricted stock unit to which they related. Each dividend equivalent right is the economic equivalent of one ordinary share. Row 2 · 2017-02-17 · Grant · Acquired 11,720 · Balance 59,371 F2: Additional ordinary shares acquired in connection with achievement in excess of target of specified performance criteria for the 2014-2016 performance period. Row 3 · 2017-02-17 · Tax withholding · Disposed 12,779 · Balance 46,592 F3: Shares withheld to pay tax liabilities incident to the vesting of restricted stock units and settlement of dividend equivalent rights. |
| Dividend Equivalent RightSEC Table II · derivative / convertible security | Direct | 685.9139 |
Reported balance
After 2017-02-17 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-02-17 · Other · Disposed 865 · Balance 685.9139 F1: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrued when and as dividends were paid on the Issuer's ordinary shares and vested proportionately with the restricted stock unit to which they related. Each dividend equivalent right is the economic equivalent of one ordinary share. |
| Ordinary SharesSEC Table I · non-derivative | IndirectJeffrey J. Owens Rev Trust | 132,763 |
Reported balance
Holding disclosure · report date 2017-02-17 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 132,763 |
Filing footnotes · ownership attribution and instrument terms
F1: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrued when and as dividends were paid on the Issuer's ordinary shares and vested proportionately with the restricted stock unit to which they related. Each dividend equivalent right is the economic equivalent of one ordinary share.
F2: Additional ordinary shares acquired in connection with achievement in excess of target of specified performance criteria for the 2014-2016 performance period.
F3: Shares withheld to pay tax liabilities incident to the vesting of restricted stock units and settlement of dividend equivalent rights.
CYPRESS SEMICONDUCTOR CORP /DE/
Report date April 16, 2020 · Filed April 17, 2020
Section 16 reporting ended · disclosed 2020-04-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-04-16 transaction · row 1
1 source rowRow 1 · 2020-04-16 · Disposition to issuer · Disposed 31,172 · Balance 0 F1: On April 16, 2020 (the "Effective Time"), pursuant to the Agreement and Plan of Merger, dated as of June 3, 2019 (the "Merger Agreement"), by and among Cypress Semiconductor Corporation (the "Issuer"), Infineon Technologies AG ("Infineon") and IFX Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer as the surviving entity and a wholly owned subsidiary of Infineon. Pursuant to the Merger Agreement, each outstanding share of the Issuer's common stock ("Common Stock") was converted into the right to receive $23.85 per share in cash (the "Per Share Merger Consideration"), without interest. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-04-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-04-16 · Disposition to issuer · Disposed 4,704 · Balance 0 F2: Restricted stock units convert into common stock on a one-for-one basis upon settlement. F4: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each outstanding restricted stock unit award, whether vested or unvested, was cancelled and converted into the right to receive a cash payment equal to the product of (i) the number of restricted stock units subject to such award immediately prior to the Effective Time multiplied by (ii) the Per Share Merger Consideration. Such payment is to be made at the times and subject to any vesting and acceleration conditions set forth in the Merger Agreement. F3: On September 25, 2017, the Reporting Person was granted 14,114 restricted stock units that vest in three equal annual installments beginning on September 25, 2018. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-04-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-04-16 · Disposition to issuer · Disposed 11,383 · Balance 0 F2: Restricted stock units convert into common stock on a one-for-one basis upon settlement. F4: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each outstanding restricted stock unit award, whether vested or unvested, was cancelled and converted into the right to receive a cash payment equal to the product of (i) the number of restricted stock units subject to such award immediately prior to the Effective Time multiplied by (ii) the Per Share Merger Consideration. Such payment is to be made at the times and subject to any vesting and acceleration conditions set forth in the Merger Agreement. F5: On May 3, 2019, the Reporting Person was granted 11,383 restricted stock units that vest on the day before the Issuer's 2020 annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: On April 16, 2020 (the "Effective Time"), pursuant to the Agreement and Plan of Merger, dated as of June 3, 2019 (the "Merger Agreement"), by and among Cypress Semiconductor Corporation (the "Issuer"), Infineon Technologies AG ("Infineon") and IFX Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer as the surviving entity and a wholly owned subsidiary of Infineon. Pursuant to the Merger Agreement, each outstanding share of the Issuer's common stock ("Common Stock") was converted into the right to receive $23.85 per share in cash (the "Per Share Merger Consideration"), without interest.
F2: Restricted stock units convert into common stock on a one-for-one basis upon settlement.
F3: On September 25, 2017, the Reporting Person was granted 14,114 restricted stock units that vest in three equal annual installments beginning on September 25, 2018.
F4: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each outstanding restricted stock unit award, whether vested or unvested, was cancelled and converted into the right to receive a cash payment equal to the product of (i) the number of restricted stock units subject to such award immediately prior to the Effective Time multiplied by (ii) the Per Share Merger Consideration. Such payment is to be made at the times and subject to any vesting and acceleration conditions set forth in the Merger Agreement.
F5: On May 3, 2019, the Reporting Person was granted 11,383 restricted stock units that vest on the day before the Issuer's 2020 annual meeting of stockholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2023 Filed Jun 13, 2023 23:17 UTC | indie Semiconductor, Inc. INDI · Entity 2432 | Exercise / conversionRestricted Stock Units · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-022008 · wf-form4_168669823659298.xml · derivative · entry 2 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Class A Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning June 10, 2022. F2 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning June 10, 2022. Read SEC document |
| June 10, 2023 Filed Jun 13, 2023 23:17 UTC | indie Semiconductor, Inc. INDI · Entity 2432 | Exercise / conversionClass A Common Stock | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-022008 · wf-form4_168669823659298.xml · nonDerivative · entry 1 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| May 04, 2023 Filed May 5, 2023 21:47 UTC | ROGERS CORP ROG · Entity 4438 | GrantCapital (Common) Stock | 950 | $0.00 | $0.00 |
DisclosureSEC source: 0001664272-23-000332 · f4_a1e2k00000rxsscuad-live.xml · nonDerivative · entry 1 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,800 F1 · shares: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 4, 2023, award of deferred stock units. Read SEC document |
| November 22, 2022 Filed Nov 22, 2022 22:04 UTC | ROGERS CORP ROG · Entity 4438 | PurchaseCapital (Common) Stock | 1,000 | $100.75 | $100,750.00 |
DisclosureSEC source: 0001664272-22-000340 · f4_a1e2k00000rxoycuat-live.xml · nonDerivative · entry 1 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,850 Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 22:24 UTC | indie Semiconductor, Inc. INDI · Entity 2432 | GrantRestricted Stock Units · Derivative | 26,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-017990 · wf-form4_165610945617496.xml · derivative · entry 1 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,965 Underlying: Class A Common Stock · 26,965 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of June 22, 2023 or the date of the Issuer's 2023 Annual Meeting of Stockholders. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of June 22, 2023 or the date of the Issuer's 2023 Annual Meeting of Stockholders. Read SEC document |
| June 10, 2022 Filed Jun 14, 2022 23:10 UTC | indie Semiconductor, Inc. INDI · Entity 2432 | Exercise / conversionRestricted Stock Units · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-017161 · wf-form4_165524822855581.xml · derivative · entry 2 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Class A Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning June 10, 2022. F2 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning June 10, 2022. Read SEC document |
| June 10, 2022 Filed Jun 14, 2022 23:10 UTC | indie Semiconductor, Inc. INDI · Entity 2432 | Exercise / conversionClass A Common Stock | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-22-017161 · wf-form4_165524822855581.xml · nonDerivative · entry 1 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| May 05, 2022 Filed May 6, 2022 16:33 UTC | ROGERS CORP ROG · Entity 4438 | GrantCapital (Common) Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001664272-22-000241 · f4_a1e2k00000rxm5juad-live.xml · nonDerivative · entry 1 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,850 F1 · shares: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 5, 2022, award of deferred stock units. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 22:41 UTC | indie Semiconductor, Inc. INDI · Entity 2432 | GrantRestricted Stock Units · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-017452 · wf-form4_162949926684119.xml · derivative · entry 1 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Class A Common Stock · 75,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock. F2 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning June 10, 2022. F2 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning June 10, 2022. Read SEC document |
| May 05, 2021 Filed May 7, 2021 15:23 UTC | ROGERS CORP ROG · Entity 4438 | GrantCapital (Common) Stock | 800 | $0.00 | $0.00 |
DisclosureSEC source: 0001664272-21-000153 · f4_a1e2k00000h7pzduaf-live.xml · nonDerivative · entry 1 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 F1 · shares: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 5, 2021, award of deferred stock units. Read SEC document |
| May 07, 2020 Filed May 11, 2020 18:21 UTC | ROGERS CORP ROG · Entity 4438 | GrantCapital (Common) Stock | 1,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001664272-20-000093 · f4_a1e2k00000krsinuat-live.xml · nonDerivative · entry 1 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,450 F1 · shares: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 7, 2020, award of deferred stock units. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 16:14 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Disposition to issuerRestricted Stock Units · Derivative | 11,383 | $23.85 | $271,484.55 |
DisclosureSEC source: 0001209191-20-024790 · doc4.xml · derivative · entry 3 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,383 shares Expires not disclosed F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon settlement. F4 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each outstanding restricted stock unit award, whether vested or unvested, was cancelled and converted into the right to receive a cash payment equal to the product of (i) the number of restricted stock units subject to such award immediately prior to the Effective Time multiplied by (ii) the Per Share Merger Consideration. Such payment is to be made at the times and subject to any vesting and acceleration conditions set forth in the Merger Agreement. F5 · derivative.exercise_date: On May 3, 2019, the Reporting Person was granted 11,383 restricted stock units that vest on the day before the Issuer's 2020 annual meeting of stockholders. F5 · derivative.expiration_date: On May 3, 2019, the Reporting Person was granted 11,383 restricted stock units that vest on the day before the Issuer's 2020 annual meeting of stockholders. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 16:14 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Disposition to issuerRestricted Stock Units · Derivative | 4,704 | $23.85 | $112,190.40 |
DisclosureSEC source: 0001209191-20-024790 · doc4.xml · derivative · entry 2 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,704 shares Expires not disclosed F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon settlement. F4 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each outstanding restricted stock unit award, whether vested or unvested, was cancelled and converted into the right to receive a cash payment equal to the product of (i) the number of restricted stock units subject to such award immediately prior to the Effective Time multiplied by (ii) the Per Share Merger Consideration. Such payment is to be made at the times and subject to any vesting and acceleration conditions set forth in the Merger Agreement. F3 · derivative.exercise_date: On September 25, 2017, the Reporting Person was granted 14,114 restricted stock units that vest in three equal annual installments beginning on September 25, 2018. F3 · derivative.expiration_date: On September 25, 2017, the Reporting Person was granted 14,114 restricted stock units that vest in three equal annual installments beginning on September 25, 2018. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 16:14 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Disposition to issuerCommon Stock | 31,172 | $23.85 | $743,452.20 |
DisclosureSEC source: 0001209191-20-024790 · doc4.xml · nonDerivative · entry 1 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: On April 16, 2020 (the "Effective Time"), pursuant to the Agreement and Plan of Merger, dated as of June 3, 2019 (the "Merger Agreement"), by and among Cypress Semiconductor Corporation (the "Issuer"), Infineon Technologies AG ("Infineon") and IFX Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer as the surviving entity and a wholly owned subsidiary of Infineon. Pursuant to the Merger Agreement, each outstanding share of the Issuer's common stock ("Common Stock") was converted into the right to receive $23.85 per share in cash (the "Per Share Merger Consideration"), without interest. Read SEC document |
| September 25, 2019 Filed Sep 26, 2019 17:45 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 4,705 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-050886 · doc4.xml · derivative · entry 2 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,704 Underlying: Common Stock · 4,705 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: On September 25, 2017, the Reporting Person was granted 14,114 restricted stock units upon the effectiveness of his appointment to the Issuer's board of directors and in accordance with the Issuer's non-employee director compensation policy (the "2017 Initial Equity Grant"). This 2017 Initial Equity Grant vests in three equal annual installments beginning on September 25, 2018. F2 · derivative.expiration_date: On September 25, 2017, the Reporting Person was granted 14,114 restricted stock units upon the effectiveness of his appointment to the Issuer's board of directors and in accordance with the Issuer's non-employee director compensation policy (the "2017 Initial Equity Grant"). This 2017 Initial Equity Grant vests in three equal annual installments beginning on September 25, 2018. Read SEC document |
| September 25, 2019 Filed Sep 26, 2019 17:45 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 4,705 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-050886 · doc4.xml · nonDerivative · entry 1 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| May 09, 2019 Filed May 13, 2019 19:34 UTC | ROGERS CORP ROG · Entity 4438 | GrantCapital (Common) Stock | 850 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-007817 · doc4.xml · nonDerivative · entry 1 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,900 F1 · shares: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 9, 2019 award of deferred stock units. Read SEC document |
| May 03, 2019 Filed May 6, 2019 20:37 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | GrantRestricted Stock Units · Derivative | 11,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-027877 · doc4.xml · derivative · entry 3 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,383 Underlying: Common Stock · 11,383 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F3 · derivative.exercise_date: On May 3, 2019, the Reporting Person was granted 11,383 restricted stock units under the Issuer's 2013 Stock Plan upon being elected to the Issuer's board of directors at the 2019 annual meeting of stockholders (the "2019 Annual Equity Grant"), which are scheduled to vest on the day before the Issuer's 2020 annual meeting of stockholders. F3 · derivative.expiration_date: On May 3, 2019, the Reporting Person was granted 11,383 restricted stock units under the Issuer's 2013 Stock Plan upon being elected to the Issuer's board of directors at the 2019 annual meeting of stockholders (the "2019 Annual Equity Grant"), which are scheduled to vest on the day before the Issuer's 2020 annual meeting of stockholders. Read SEC document |
| May 02, 2019 Filed May 6, 2019 20:37 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 12,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-027877 · doc4.xml · derivative · entry 2 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,353 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: On May 11, 2018, the Reporting Person was granted 12,353 restricted stock units under the Issuer's 2013 Stock Plan upon being elected to the Issuer's board of directors at the 2018 annual meeting of stockholders (the "2018 Annual Equity Grant"), which were scheduled to vest on the day before the Issuer's 2019 annual meeting of stockholders. F2 · derivative.expiration_date: On May 11, 2018, the Reporting Person was granted 12,353 restricted stock units under the Issuer's 2013 Stock Plan upon being elected to the Issuer's board of directors at the 2018 annual meeting of stockholders (the "2018 Annual Equity Grant"), which were scheduled to vest on the day before the Issuer's 2019 annual meeting of stockholders. Read SEC document |
| May 02, 2019 Filed May 6, 2019 20:37 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 12,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-027877 · doc4.xml · nonDerivative · entry 1 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| September 25, 2018 Filed Sep 26, 2018 17:22 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 4,705 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052323 · doc4.xml · derivative · entry 2 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,409 Underlying: Common Stock · 4,705 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: On September 25, 2017, the Reporting Person was granted 14,114 restricted stock units upon the effectiveness of his appointment to the Issuer's board of directors and in accordance with the Issuer's non-employee director compensation policy (the "2017 Initial Equity Grant"). This 2017 Initial Equity Grant vests in three equal annual installments beginning on September 25, 2018. F2 · derivative.expiration_date: On September 25, 2017, the Reporting Person was granted 14,114 restricted stock units upon the effectiveness of his appointment to the Issuer's board of directors and in accordance with the Issuer's non-employee director compensation policy (the "2017 Initial Equity Grant"). This 2017 Initial Equity Grant vests in three equal annual installments beginning on September 25, 2018. Read SEC document |
| September 25, 2018 Filed Sep 26, 2018 17:22 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 4,705 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052323 · doc4.xml · nonDerivative · entry 1 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,114 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| May 11, 2018 Filed May 14, 2018 20:11 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | GrantRestricted Stock Units · Derivative | 12,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-030072 · doc4.xml · derivative · entry 3 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,353 Underlying: Common Stock · 12,353 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F3 · derivative.exercise_date: On May 11, 2018, the Reporting Person was awarded a grant of 12,353 restricted stock units upon election to the Issuer's board of directors at the Issuer's 2018 annual meeting of stockholders (the "2018 Annual Equity Grant"). This 2018 Annual Equity Grant to non-employee members of the Issuer's board of directors represents a contingent right to receive Issuer common stock on a one-for-one basis upon vesting and is fully vested on the day before the Issuer's 2019 annual meeting of stockholders. F3 · derivative.expiration_date: On May 11, 2018, the Reporting Person was awarded a grant of 12,353 restricted stock units upon election to the Issuer's board of directors at the Issuer's 2018 annual meeting of stockholders (the "2018 Annual Equity Grant"). This 2018 Annual Equity Grant to non-employee members of the Issuer's board of directors represents a contingent right to receive Issuer common stock on a one-for-one basis upon vesting and is fully vested on the day before the Issuer's 2019 annual meeting of stockholders. Read SEC document |
| May 10, 2018 Filed May 14, 2018 20:11 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 9,409 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-030072 · doc4.xml · derivative · entry 2 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,409 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: On September 25, 2017, the Reporting Person was awarded a grant of 9,409 restricted stock units upon his appointment to the Issuer's board of directors on September 25, 2017 (the "2017 Annual Equity Grant"). The number of restricted stock units underlying this 2017 Annual Equity Grant was prorated to reflect the Reporting Person's appointment date to the Issuer's board of directors. This 2017 Annual Equity Grant to non-employee members of the Issuer's board of directors represents a contingent right to receive Issuer common stock on a one-for-one basis upon vesting and is fully vested on the day before the Issuer's 2018 annual meeting of stockholders. F2 · derivative.expiration_date: On September 25, 2017, the Reporting Person was awarded a grant of 9,409 restricted stock units upon his appointment to the Issuer's board of directors on September 25, 2017 (the "2017 Annual Equity Grant"). The number of restricted stock units underlying this 2017 Annual Equity Grant was prorated to reflect the Reporting Person's appointment date to the Issuer's board of directors. This 2017 Annual Equity Grant to non-employee members of the Issuer's board of directors represents a contingent right to receive Issuer common stock on a one-for-one basis upon vesting and is fully vested on the day before the Issuer's 2018 annual meeting of stockholders. Read SEC document |
| May 10, 2018 Filed May 14, 2018 20:11 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 9,409 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-030072 · doc4.xml · nonDerivative · entry 1 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,409 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| May 03, 2018 Filed May 7, 2018 18:34 UTC | ROGERS CORP ROG · Entity 4438 | GrantCapital (Common) Stock | 1,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-008785 · doc4.xml · nonDerivative · entry 1 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,050 F1 · shares: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 3, 2018 award of deferred stock units. Read SEC document |
| September 25, 2017 Filed Sep 27, 2017 16:54 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | GrantRestricted Stock Units · Derivative | 9,409 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-054138 · doc4.xml · derivative · entry 2 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,409 Underlying: Common Stock · 9,409 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F4 · date: Acquired upon the appointment of the Reporting Person to the Issuer's board of directors on September 25, 2017 (the "Annual Equity Grant"). F5 · shares: This Annual Equity Grant to the Reporting Person was pro-rated to a grant date value of approximately $133,333 (from $200,000) to reflect his September 25, 2017 initial appointment to the Issuer's board of directors. F6 · derivative.exercise_date: This Annual Equity Grant to the non-employee members of the Issuer's board of directors represents a contingent right to receive Issuer common stock on a one-for-one basis upon vesting and is fully vested on the day before the Issuer's next annual meeting of stockholders. F6 · derivative.expiration_date: This Annual Equity Grant to the non-employee members of the Issuer's board of directors represents a contingent right to receive Issuer common stock on a one-for-one basis upon vesting and is fully vested on the day before the Issuer's next annual meeting of stockholders. Read SEC document |
| September 25, 2017 Filed Sep 27, 2017 16:54 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | GrantRestricted Stock Units · Derivative | 14,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-054138 · doc4.xml · derivative · entry 1 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,114 Underlying: Common Stock · 14,114 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F2 · date: Acquired upon the appointment of the Reporting Person to the Issuer's board of directors on September 25, 2017 (the "Initial Equity Grant"). F3 · derivative.exercise_date: This Initial Equity Grant to the non-employee members of the Issuer's board of directors represents a contingent right to receive Issuer common stock on a one-for-one basis upon vesting and will vest in three equal annual installments beginning on September 25, 2018. F3 · derivative.expiration_date: This Initial Equity Grant to the non-employee members of the Issuer's board of directors represents a contingent right to receive Issuer common stock on a one-for-one basis upon vesting and will vest in three equal annual installments beginning on September 25, 2018. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 22:46 UTC | ROGERS CORP ROG · Entity 4438 | GrantCapital (Common) Stock | 850 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-013312 · doc4.xml · nonDerivative · entry 1 OWENS JEFFREY J · CIK 0001193575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 850 F1 · shares: Mr. Owens was appointed to the Board of Directors of Issuer on August 2, 2017. This figure represents the number of shares of the Issuer's Capital (Common) Stock receivable pursuant to the deferred stock units granted to Mr. Owens on such date. The award is consistent with Issuer's compensatory arrangements for non-management directors, as described in the proxy statement filed on March 22, 2017, and has been prorated based on the date of Mr. Owens' appointment to the Board. Read SEC document |
| February 17, 2017 Filed Feb 22, 2017 21:03 UTC | Aptiv PLC DLPH · Entity 3559 | OtherDividend Equivalent Right · Derivative | 865 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-013158 · doc4.xml · derivative · entry 5 OWENS JEFFREY J · CIK 0001193575 · EVP & Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 685.9139 Underlying: Ordinary Shares · 865 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrued when and as dividends were paid on the Issuer's ordinary shares and vested proportionately with the restricted stock unit to which they related. Each dividend equivalent right is the economic equivalent of one ordinary share. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrued when and as dividends were paid on the Issuer's ordinary shares and vested proportionately with the restricted stock unit to which they related. Each dividend equivalent right is the economic equivalent of one ordinary share. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrued when and as dividends were paid on the Issuer's ordinary shares and vested proportionately with the restricted stock unit to which they related. Each dividend equivalent right is the economic equivalent of one ordinary share. Read SEC document |
| February 17, 2017 Filed Feb 22, 2017 21:03 UTC | Aptiv PLC DLPH · Entity 3559 | Tax withholdingOrdinary Shares | 12,779 | $75.46 | $964,303.34 |
DisclosureSEC source: 0001209191-17-013158 · doc4.xml · nonDerivative · entry 3 OWENS JEFFREY J · CIK 0001193575 · EVP & Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,592 F3 · price: Shares withheld to pay tax liabilities incident to the vesting of restricted stock units and settlement of dividend equivalent rights. Read SEC document |
| February 17, 2017 Filed Feb 22, 2017 21:03 UTC | Aptiv PLC DLPH · Entity 3559 | GrantOrdinary Shares | 11,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-013158 · doc4.xml · nonDerivative · entry 2 OWENS JEFFREY J · CIK 0001193575 · EVP & Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,371 F2 · price: Additional ordinary shares acquired in connection with achievement in excess of target of specified performance criteria for the 2014-2016 performance period. Read SEC document |
| February 17, 2017 Filed Feb 22, 2017 21:03 UTC | Aptiv PLC DLPH · Entity 3559 | OtherOrdinary Shares | 865 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-013158 · doc4.xml · nonDerivative · entry 1 OWENS JEFFREY J · CIK 0001193575 · EVP & Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,651 F1 · price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrued when and as dividends were paid on the Issuer's ordinary shares and vested proportionately with the restricted stock unit to which they related. Each dividend equivalent right is the economic equivalent of one ordinary share. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 18:29 UTC | Aptiv PLC DLPH · Entity 3559 | GrantDividend Equivalent Right · Derivative | 183.151 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-011937 · doc4.xml · derivative · entry 1 OWENS JEFFREY J · CIK 0001193575 · EVP & Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,550.9139 Underlying: Ordinary Shares · 183.151 shares Expires not disclosed F1 · derivative.exercise_price: The dividend equivalent rights accrued with respect to an outstanding award of restricted stock units. Each dividend equivalent right is the economic equivalent of one ordinary share. F1 · derivative.exercise_date: The dividend equivalent rights accrued with respect to an outstanding award of restricted stock units. Each dividend equivalent right is the economic equivalent of one ordinary share. F1 · derivative.expiration_date: The dividend equivalent rights accrued with respect to an outstanding award of restricted stock units. Each dividend equivalent right is the economic equivalent of one ordinary share. Read SEC document |
| November 23, 2016 Filed Nov 28, 2016 17:04 UTC | Aptiv PLC DLPH · Entity 3559 | GrantDividend Equivalent Right · Derivative | 207.3536 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-152111 · doc4.xml · derivative · entry 1 OWENS JEFFREY J · CIK 0001193575 · EVP & Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,367.7629 Underlying: Ordinary Shares · 207.3536 shares Expires not disclosed F1 · derivative.exercise_price: The dividend equivalent rights accrued with respect to an outstanding award of restricted stock units. Each dividend equivalent right is the economic equivalent of one ordinary share. F1 · derivative.exercise_date: The dividend equivalent rights accrued with respect to an outstanding award of restricted stock units. Each dividend equivalent right is the economic equivalent of one ordinary share. F1 · derivative.expiration_date: The dividend equivalent rights accrued with respect to an outstanding award of restricted stock units. Each dividend equivalent right is the economic equivalent of one ordinary share. Read SEC document |
| March 11, 2016 Filed Feb 8, 2017 13:48 UTC | Aptiv PLC DLPH · Entity 3559 | GiftOrdinary Shares | 57,185 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-008505 · doc5.xml · nonDerivative · entry 1 OWENS JEFFREY J · CIK 0001193575 · EVP & Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,786 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.